Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in PTSD
NCT02019940Phase 1Completed
- Sponsor
- Yale University
- Start
- Jan 2014
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of riluzole in post-traumatic stress disorder (PTSD), sponsored by Yale University. Primary endpoint: Clinician Administered PTSD Scale at 12 weeks. Started Jan 2014; status: completed.
02
Drugs
riluzole
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02019940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019940.